JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.63B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 3 |
JPMorgan BetaBuilders International Equity ETF
BBIN
|
+$1.55B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$884M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.8B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.77B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$884M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$880M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$834M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.09% |
| 2 | Technology | 16.19% |
| 3 | Financials | 10.76% |
| 4 | Healthcare | 10.54% |
| 5 | Consumer Discretionary | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
351
Old Dominion Freight Line
ODFL
$37.4B
| $271M | 0.05% |
3,198,152
-114,452
| -3% | -$8.69M |
2013 Q2
28 quarters
|
|
352
ResMed
RMD
$30.8B
| $270M | 0.05% |
1,407,876
+176,596
| +14% | +$28.9M |
2013 Q2
28 quarters
|
|
353
New York Times
NYT
$10.1B
| $269M | 0.05% |
6,409,357
-48,476
| -0.8% | -$1.76M |
2016 Q4
14 quarters
|
|
354
Otis Worldwide
OTIS
$24.4B
| $267M | 0.05% |
+4,700,675
| New | +$244M |
2020 Q2
0 quarters
|
|
355
American Electric Power
AEP
$65.1B
| $267M | 0.05% |
3,355,566
-1,390,479
| -29% | -$113M |
2013 Q2
28 quarters
|
|
356
Vanguard S&P 500 Growth ETF
VOOG
$27.9B
| $267M | 0.05% |
8,568,870
-126,966
| -1% | -$3.66M |
2016 Q4
14 quarters
|
|
|
DISH
357
DELISTED
DISH Network Corp.
DISH
| $265M | 0.05% |
7,692,267
-2,702,982
| -26% | -$75.2M |
2013 Q2
28 quarters
|
|
358
HubSpot
HUBS
$10.7B
| $265M | 0.05% |
1,182,173
+510,151
| +76% | +$91.7M |
2014 Q4
22 quarters
|
|
359
Centene
CNC
$31.1B
| $263M | 0.05% |
4,144,366
-1,820,810
| -31% | -$119M |
2013 Q2
28 quarters
|
|
360
Newmont
NEM
$122B
| $262M | 0.05% |
4,248,736
-192,493
| -4% | -$11.4M |
2013 Q2
28 quarters
|
|
361
Okta
OKTA
$37B
| $262M | 0.05% |
1,306,822
+177,673
| +16% | +$30.2M |
2017 Q2
12 quarters
|
|
|
HZNP
362
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $261M | 0.05% |
4,699,798
+565,700
| +14% | +$24.2M |
2014 Q4
22 quarters
|
|
363
TC Energy
TRP
$61.5B
| $261M | 0.05% |
6,091,263
-2,959,331
| -33% | -$133M |
2013 Q2
28 quarters
|
|
364
JPMorgan Chase
JPM
$884B
| $260M | 0.05% |
2,761,663
-67,281
| -2% | -$6.38M |
2014 Q3
23 quarters
|
|
365
EOG Resources
EOG
$74.2B
| $259M | 0.05% |
5,112,942
+678,439
| +15% | +$32.9M |
2013 Q2
28 quarters
|
|
366
Take-Two Interactive
TTWO
$37.9B
| $257M | 0.05% |
1,842,141
-1,028,041
| -36% | -$134M |
2013 Q2
28 quarters
|
|
367
Elevance Health
ELV
$83.8B
| $257M | 0.05% |
976,326
-256,658
| -21% | -$68.5M |
2013 Q2
28 quarters
|
|
368
American Tower
AMT
$75.6B
| $256M | 0.05% |
991,072
+85,007
| +9% | +$21M |
2013 Q2
28 quarters
|
|
369
AptarGroup
ATR
$7.62B
| $254M | 0.05% |
2,265,709
-85,972
| -4% | -$9.15M |
2013 Q2
28 quarters
|
|
370
Labcorp
LH
$25B
| $253M | 0.05% |
1,774,385
+51,162
| +3% | +$7.08M |
2013 Q2
28 quarters
|
|
371
Sarepta Therapeutics
SRPT
$1.85B
| $253M | 0.05% |
1,577,913
+433,450
| +38% | +$59M |
2015 Q4
18 quarters
|
|
372
Weyerhaeuser
WY
$13.3B
| $253M | 0.05% |
11,251,893
+1,152,664
| +11% | +$23.3M |
2013 Q2
28 quarters
|
|
373
Oracle
ORCL
$431B
| $252M | 0.05% |
4,556,500
+1,664,368
| +58% | +$88.2M |
2013 Q2
28 quarters
|
|
374
Toro Company
TTC
$9.34B
| $251M | 0.05% |
3,781,298
-177,341
| -4% | -$11.6M |
2013 Q2
28 quarters
|
|
375
Vanguard Short-Term Bond ETF
BSV
$45.9B
| $251M | 0.05% |
3,016,074
-173,432
| -5% | -$14.3M |
2013 Q2
28 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2020 Portfolio in Review
As of Q2 2020, JP Morgan Chase held 5,976 positions worth $518B, up 22% from $426B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2020 filing shows 640 new, 2,055 increased, 2,340 reduced and 398 closed positions. Its largest new stake was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.8B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2020 buy was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2020, an estimated $2.63B increase.
- JP Morgan Chase's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.8B.
- JP Morgan Chase fully exited Allergan plc in Q2 2020, selling an estimated $656M.
- JP Morgan Chase's ten largest holdings make up 17% of its $518B portfolio in Q2 2020.
- JP Morgan Chase opened 640 new positions and closed 398 in Q2 2020.
- JP Morgan Chase's portfolio value rose 22% quarter-over-quarter to $518B.
Based on JP Morgan Chase's 13F filing for Q2 2020, filed 11 Aug 2020.